(19)
(11) EP 3 079 657 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.05.2019 Bulletin 2019/20

(45) Mention of the grant of the patent:
20.03.2019 Bulletin 2019/12

(21) Application number: 14809015.2

(22) Date of filing: 08.12.2014
(51) International Patent Classification (IPC): 
A61K 9/06(2006.01)
A61K 47/22(2006.01)
A61K 31/198(2006.01)
A61K 8/20(2006.01)
A61K 9/00(2006.01)
A61Q 11/00(2006.01)
 A61K 47/02(2006.01)
A61K 47/38(2006.01)
A61K 8/44(2006.01)
A61K 33/20(2006.01)
A61K 47/18(2017.01)
(86) International application number:
PCT/EP2014/076909
(87) International publication number:
WO 2015/086535 (18.06.2015 Gazette 2015/24)

(54)

PREPARATION FOR PREVENTION AND/OR TREATMENT OF PERI-IMPLANTITIS

PRÄPARAT ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON PERIIMPLANTITIS

PRÉPARATION POUR LA PRÉVENTION ET/OU LE TRAITEMENT DE LA PÉRI-IMPLANTITE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 09.12.2013 SE 1351468
11.04.2014 SE 1450452

(43) Date of publication of application:
19.10.2016 Bulletin 2016/42

(73) Proprietor: RLS Global AB
431 53 Mölndal (SE)

(72) Inventors:
  • ALMHÖJD, Ulrica
    47537 Bohus-Björkö (SE)
  • FORNELL, Jan
    11538 Stockholm (SE)

(74) Representative: Valea AB 
Box 17067
200 10 Malmö
200 10 Malmö (SE)


(56) References cited: : 
EP-A1- 0 938 282
 WO-A2-2012/172071
   
  • RALF BRGERS ET AL: "The effect of various topical peri-implantitis antiseptics on,, and", ARCHIVES OF ORAL BIOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 57, no. 7, 28 January 2012 (2012-01-28), pages 940-947, XP028499457, ISSN: 0003-9969, DOI: 10.1016/J.ARCHORALBIO.2012.01.015 [retrieved on 2012-02-04]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).